Quarterly report · Q1
4539.TEDINET S100RKNA
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.5bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥106m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥175m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥111m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥58m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥514m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥111m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥925m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥79m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥339m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥653m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥79m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥653m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥52.1bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥48.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥51.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥30.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.4bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥22.03 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.07 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.91 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥239m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥237m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥5m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥2m |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.3bn |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.3bn |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥0 |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥101m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | −¥106m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥211m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥210m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥21m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥2m |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥8.2bn |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥8.2bn |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E00957-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥196m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 396
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income | Prior1YTDDuration | 291000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 42000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 291000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 42000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Advertising expenses sga | Prior1YTDDuration | 12000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 19000000 | JPY |
| Traveling and transportation expenses sga | Prior1YTDDuration | 67000000 | JPY |
| Traveling and transportation expenses sga | CurrentYTDDuration | 90000000 | JPY |
| Salaries sga | Prior1YTDDuration | 670000000 | JPY |
| Salaries sga | CurrentYTDDuration | 621000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 34000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 13000000 | JPY |
| Commission fee sga | Prior1YTDDuration | 357000000 | JPY |
| Commission fee sga | CurrentYTDDuration | 305000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 445000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 463000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 8214000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 210000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 8425000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 8425000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 0 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 8216000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 211000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 8427000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Net sales | Prior1YTDDuration | 8425000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 196000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -21000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 175000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 175000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 7299000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 237000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 7537000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 7537000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00957-000MedicineReportableSegmentsMember | 7299000000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 239000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |